Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of GBP 20.94 billion. The enterprise value is 23.39 billion.

Market Cap	20.94B
Enterprise Value	23.39B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Dec 6, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+4.36%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	141.36M

Valuation Ratios

The trailing PE ratio is 37.15.

PE Ratio	37.15
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.62, with an EV/FCF ratio of 131.01.

EV / Earnings	41.49
EV / Sales	7.72
EV / EBITDA	24.62
EV / EBIT	28.55
EV / FCF	131.01

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.26.

Current Ratio	1.02
Quick Ratio	0.62
Debt / Equity	1.26
Debt / EBITDA	2.67
Debt / FCF	14.14
Interest Coverage	9.19

Financial Efficiency

Return on equity (ROE) is 28.67% and return on invested capital (ROIC) is 11.80%.

Return on Equity (ROE)	28.67%
Return on Assets (ROA)	9.49%
Return on Invested Capital (ROIC)	11.80%
Return on Capital Employed (ROCE)	19.30%
Revenue Per Employee	181,276
Profits Per Employee	33,881
Employee Count	16,639
Asset Turnover	0.56
Inventory Turnover	2.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.43% in the last 52 weeks. The beta is 0.34, so Coloplast's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	+6.43%
50-Day Moving Average	832.33
200-Day Moving Average	867.72
Relative Strength Index (RSI)	57.41
Average Volume (20 Days)	22,802

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Coloplast had revenue of GBP 3.02 billion and earned 563.75 million in profits. Earnings per share was 2.51.

Revenue	3.02B
Gross Profit	2.04B
Operating Income	815.60M
Pretax Income	713.61M
Net Income	563.75M
EBITDA	914.02M
EBIT	815.60M
Earnings Per Share (EPS)	2.51

Full Income Statement

Balance Sheet

The company has 87.93 million in cash and 2.53 billion in debt, giving a net cash position of -2.44 billion.

Cash & Cash Equivalents	87.93M
Total Debt	2.53B
Net Cash	-2.44B
Net Cash Per Share	n/a
Equity (Book Value)	2.00B
Book Value Per Share	8.89
Working Capital	26.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 308.65 million and capital expenditures -130.11 million, giving a free cash flow of 178.54 million.

Operating Cash Flow	308.65M
Capital Expenditures	-130.11M
Free Cash Flow	178.54M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 67.59%, with operating and profit margins of 27.04% and 18.69%.

Gross Margin	67.59%
Operating Margin	27.04%
Pretax Margin	23.66%
Profit Margin	18.69%
EBITDA Margin	30.30%
EBIT Margin	27.04%
FCF Margin	5.92%

Dividends & Yields

This stock pays an annual dividend of 2.47, which amounts to a dividend yield of 0.29%.

Dividend Per Share	2.47
Dividend Yield	0.29%
Dividend Growth (YoY)	1.76%
Years of Dividend Growth	9
Payout Ratio	93.43%
Buyback Yield	-4.36%
Shareholder Yield	-4.07%
Earnings Yield	2.69%
FCF Yield	0.85%

Dividend Details

Stock Splits

The last stock split was on December 19, 2012. It was a forward split with a ratio of 5.

Last Split Date	Dec 19, 2012
Split Type	Forward
Split Ratio	5

Scores

Coloplast has an Altman Z-Score of 5.4.

Altman Z-Score	5.4
Piotroski F-Score	n/a